CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.88% | 6.70% | 3.09% | 2.88% | 5.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.88% | 6.70% | 3.09% | 2.88% | 5.78% |
| Cost of Revenue | 32.09% | 7.77% | 0.38% | 1.01% | 4.36% |
| Gross Profit | -10.44% | 5.88% | 5.27% | 4.37% | 6.88% |
| SG&A Expenses | 2.26% | 9.64% | 5.05% | 11.54% | 2.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.88% | 8.37% | 2.46% | 5.58% | 3.05% |
| Operating Income | -48.26% | -5.27% | 7.88% | -22.43% | 24.22% |
| Income Before Tax | -32.97% | -92.43% | -20.25% | -69.82% | 7.27% |
| Income Tax Expenses | 26.57% | -81.07% | 12.74% | -71.35% | 29.89% |
| Earnings from Continuing Operations | -50.41% | -94.16% | -28.54% | -69.37% | 2.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.41% | -94.16% | -28.54% | -69.37% | 2.07% |
| EBIT | -48.26% | -5.27% | 7.88% | -22.43% | 24.22% |
| EBITDA | -35.12% | -2.48% | 6.68% | -13.58% | 17.98% |
| EPS Basic | -50.49% | -94.18% | -28.85% | -69.56% | 1.53% |
| Normalized Basic EPS | -55.57% | -1.65% | 14.68% | -27.00% | 32.55% |
| EPS Diluted | -49.97% | -94.27% | -28.13% | -69.84% | 2.79% |
| Normalized Diluted EPS | -55.34% | -1.13% | 15.38% | -26.26% | 34.79% |
| Average Basic Shares Outstanding | 0.15% | 0.32% | 0.44% | 0.63% | 0.54% |
| Average Diluted Shares Outstanding | -0.37% | -0.20% | -0.17% | -0.39% | -1.13% |
| Dividend Per Share | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.02% | 16.21% | 0.41% | 2.28% | -0.02% |